Literature DB >> 10523238

Autoimmune skin rashes associated with etanercept for rheumatoid arthritis.

P H Brion, A Mittal-Henkle, K C Kalunian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523238     DOI: 10.7326/0003-4819-131-8-199910190-00031

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  13 in total

Review 1.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

Review 2.  Safety of etanercept in psoriasis: a critical review.

Authors:  Jose L Sánchez Carazo; Laura Mahiques Santos; Vicente Oliver Martinez
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  A case of cellulitis causing tissue defect during etanercept therapy.

Authors:  Dulgeroglu Deniz; Umay Ebru; Bal Ajda; Tetik Menevse Gulsum; Tatlican Semih; Cakci Aytul
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 2.631

Review 4.  Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

Authors:  Christine R Culy; Gillian M Keating
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Urticaria and angiedema-like skin reactions in a patient treated with adalimumab.

Authors:  S N Nikas; P V Voulgari; A A Drosos
Journal:  Clin Rheumatol       Date:  2006-01-19       Impact factor: 2.980

Review 6.  Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.

Authors:  Roy Fleischmann; Imran Iqbal; Pallavi Nandeshwar; Andres Quiceno
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity.

Authors:  Paola Caramaschi; Domenico Biasi; Marco Colombatti; Sara Pieropan; Nicola Martinelli; Antonio Carletto; Alessandro Volpe; Luisa Maria Pacor; Lisa Maria Bambara
Journal:  Rheumatol Int       Date:  2004-12-31       Impact factor: 2.631

Review 8.  Management of autoimmune skin disorders in the elderly.

Authors:  Wei Jing Loo; Nigel P Burrows
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs.

Authors:  Ditina Desai; Raphaela Goldbach-Mansky; Joshua D Milner; Ronald L Rabin; Keith Hull; Frank Pucino; Nona Colburn
Journal:  Ann Pharmacother       Date:  2009-05       Impact factor: 3.154

Review 10.  Vasculitis induced by tumor necrosis factor-targeted therapies.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.